Featured Research

from universities, journals, and other organizations

CEUS: To Diagnose Postoperative Vascular Complications After Liver Transplantation

Date:
August 12, 2009
Source:
World Journal of Gastroenterology
Summary:
Conventional ultrasound including 2D and Doppler ultrasound plays an important role in screening for postoperative vascular complications after liver transplantation, but vascular visualization is not always satisfactory.

Conventional ultrasound including 2D and Doppler ultrasound plays an important role in screening for postoperative vascular complications after liver transplantation, but vascular visualization is not always satisfactory.

A research article to be published on August 7, 2009 in the World Journal of Gastroenterology addresses this question. Contrast-enhanced ultrasound (CEUS) has been applied gradually in recent years because of its fine vascular tracing and perfusion visualization.

A research team led by Professor Yan Luo from West China Hospital found that CEUS improved the flow visualization of the hepatic artery, portal and hepatic veins and bridging vein, as well as evaluation of liver graft parenchyma perfusion.

CEUS has high sensitivity and specificity for finding hepatic artery thrombosis, hepatic artery stenosis, portal vein thrombosis and liver infarction. CEUS can be performed at the bedside, and has no iodine allergy or X-ray exposure. Therefore, this new technique should be used more frequently after liver transplantation.

Although this study included a limited number of patients, the research is interesting and the results are useful for diagnosis of vascular complications early after liver transplantation.


Story Source:

The above story is based on materials provided by World Journal of Gastroenterology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Luo Y, Fan YT, Lu Q, Li B, Wen TF, Zhang ZW. CEUS: A new imaging approach for postoperative vascular complications after right-lobe LDLT. World J Gastroenterol, 2009; 15(29): 3670-3675 [link]

Cite This Page:

World Journal of Gastroenterology. "CEUS: To Diagnose Postoperative Vascular Complications After Liver Transplantation." ScienceDaily. ScienceDaily, 12 August 2009. <www.sciencedaily.com/releases/2009/08/090812092146.htm>.
World Journal of Gastroenterology. (2009, August 12). CEUS: To Diagnose Postoperative Vascular Complications After Liver Transplantation. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2009/08/090812092146.htm
World Journal of Gastroenterology. "CEUS: To Diagnose Postoperative Vascular Complications After Liver Transplantation." ScienceDaily. www.sciencedaily.com/releases/2009/08/090812092146.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
New Drug Could Reduce Cardiovascular Deaths

New Drug Could Reduce Cardiovascular Deaths

Newsy (Aug. 30, 2014) The new drug from Novartis could reduce cardiovascular deaths by 20 percent compared to other similar drugs. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins